NOVADIP BIOSCIENCES
De berekende faillissementskans van NOVADIP BIOSCIENCES over 12 maanden bedraagt 0,3% (zeer laag). Het bedrijf is actief sinds 2013 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 13 jaar |
| Bestuur | 8 |
| Vestigingen | 1 |
| Publicaties | 23 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | volledig | 10-07-2025 | 2025-00259275 |
| 31-12-2023 | volledig | 05-06-2024 | 2024-00124948 |
| 31-12-2022 | volledig | 08-06-2023 | 2023-00113121 |
| 31-12-2021 | volledig | 16-05-2022 | 2022-20026958 |
| 31-12-2020 | volledig | 27-05-2021 | 2021-15800330 |
| 31-12-2019 | volledig | 02-06-2020 | 2020-13800259 |
| 31-12-2018 | volledig | 05-06-2019 | 2019-15800292 |
| 31-12-2017 | volledig | 08-06-2018 | 2018-16500489 |
| 31-12-2016 | volledig | 24-05-2017 | 2017-13000138 |
| 31-12-2015 | volledig | 12-05-2016 | 2016-12200469 |
-
Axxis V&CRechtspersoonBestuurder· vast vert.: Gil BeyenStaatsblad-akte 21364627 (03-11-2021)Actief03-11-2021 → heden
-
SOPARTECRechtspersoonBestuurder· vast vert.: Philippe François DurieuxStaatsblad-akte 21364627 (03-11-2021)Actief03-11-2021 → heden
-
SPARAXISRechtspersoonBestuurder· vast vert.: Christina FranssenStaatsblad-akte 21364627 (03-11-2021)Actief03-11-2021 → heden
-
Theracell ConsultingRechtspersoonBestuurder· vast vert.: Denis DufraneStaatsblad-akte 21364627 (03-11-2021)Actief03-11-2021 → heden
-
Actief03-11-2021 → heden
-
Actief01-07-2019 → heden
2 gebeurtenissen
- 03-11-2021 Mandaat verlengd· Bestuurder
- 01-07-2019 Benoemd· Bestuurder
Toon 2 andere zittende bestuurders
-
Actief01-07-2019 → heden
2 gebeurtenissen
- 03-11-2021 Mandaat verlengd· Bestuurder
- 01-07-2019 Mandaat verlengd· Bestuurder
-
Actief01-07-2019 → heden
2 gebeurtenissen
- 03-11-2021 Mandaat verlengd· Bestuurder
- 01-07-2019 Mandaat verlengd· Bestuurder
Historisch, niet recent bevestigd (7)
-
Theracell ConsultingRechtspersoonGedelegeerd bestuurder· vast vert.: Dr Denis DufraneStaatsblad-akte 20040586 (16-03-2020)Niet recent bevestigdlaatst bevestigd in akte van 2020
-
IntégraleRechtspersoonBestuurder· vast vert.: Cédric SacréStaatsblad-akte 19086628 (01-07-2019)Niet recent bevestigdlaatst bevestigd in akte van 2019
-
Sopartec SARechtspersoonBestuurder· vast vert.: Philippe DurieuxStaatsblad-akte 19086628 (01-07-2019)Niet recent bevestigdlaatst bevestigd in akte van 2019
-
Sparaxis SARechtspersoonBestuurder· vast vert.: Christine FranssenStaatsblad-akte 19086628 (01-07-2019)Niet recent bevestigdlaatst bevestigd in akte van 2019
-
Niet recent bevestigdlaatst bevestigd in akte van 2019
-
Niet recent bevestigdlaatst bevestigd in akte van 2019
-
CONTHEGAS SPRLRechtspersoonGedelegeerd bestuurder· vast vert.: Jean-François POLLETStaatsblad-akte 15091181 (26-06-2015)Niet recent bevestigdlaatst bevestigd in akte van 2015
Voormalige bestuurders (4)
-
Voormalig- → 23-12-2019
-
Aetes GmbHRechtspersoonBestuurder· vast vert.: Eric PâquesStaatsblad-akte 17079057 (06-06-2017)Voormalig06-06-2017 → 01-07-2019
2 gebeurtenissen
- 01-07-2019 Ontslagen· Bestuurder
- 06-06-2017 Benoemd· Bestuurder
-
CONTHEGAS CONSULTINGRechtspersoonBestuurder· vast vert.: Jean-François PolletStaatsblad-akte 19304899 (30-01-2019)Voormalig- → 31-12-2018
-
Voormalig26-06-2015 → 20-12-2018
2 gebeurtenissen
- 20-12-2018 Ontslagen· Bestuurder
- 26-06-2015 Benoemd· Bestuurder
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| SRL DELOITTE Réviseurs d'EntreprisesActief Commissaris · vertegenwoordigd door Julie Delforge |
- | 28-11-2022 → heden |
Toon 2 eerdere commissarissen
| PricewaterhouseCoopers Reviseurs d'Entreprises Commissaris · vertegenwoordigd door Patrick Mortroux opgevolgd door SCRL PwC Réviseurs d'Entreprises in 2019 |
- | 03-06-2016 → 01-07-2019 |
| SCRL PwC Réviseurs d'Entreprises Commissaris · vertegenwoordigd door Patrick Mortroux opgevolgd door SRL DELOITTE Réviseurs d'Entreprises in 2022 |
- | 01-07-2019 → 28-11-2022 |
| NACE primair | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 31-05-2013 |
| Status | Actief |
| Postcode | 1435 |
Toon 2 andere netwerkverbindingen
Elke band vermeldt waarop de claim steunt. Een bestuurszetel is invloed op het bestuur, geen eigendom. Gerechtelijke mandaten (curator, voorlopig bewindvoerder) en vereffeningsmandaten verbinden bedrijven niet en staan hier daarom niet in; ze horen bij Bestuurders & mandaten.
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 25020B0074/00B002 | Wallonië | 6,2 ha | 1 · 17 m² | 7,8 m · 2 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
Wij kennen 25 Staatsblad-aktes van dit bedrijf. Daarvan is er nog geen enkele gelezen: wat erin staat, is hier niet vastgesteld en ook niet weerlegd.
06-05-2026 General meeting · Officer resignation · Officer appointment · Officer reappointment
- Filing: 2026-05-04 · NOVADIP BIOSCIENCES
- General meeting: 2021-10-20 · NOVADIP BIOSCIENCES
- Officer resignation: date: 2021-10-20, role: administrateur · INTEGRALE
- Officer appointment: date: 2021-10-20, role: administrateur, presenter: CR-CP (Novel Ventures Limited) · Yi Zhou
- Officer reappointment: date: 2021-10-20, role: administrateur, presenter: NSV · Jean Pierre Bizet
- Officer reappointment: date: 2021-10-20, role: administrateur, presenter: Fund+ · Philippe Monteyne
- Officer reappointment: date: 2021-10-20, role: administrateur, presenter: SRIW, permanent_representative: Christina Franssen · SPARAXIS
- Officer reappointment: date: 2021-10-20, role: administrateur, presenter: Investisseurs, permanent_representative: Philippe François Durieux · SOPARTEC
- Officer reappointment: date: 2021-10-20, role: administrateur indépendant · Eric Pâques
- Officer reappointment: date: 2021-10-20, role: administrateur, permanent_representative: Gil Beyen · Axxis V&C
- Officer reappointment: date: 2021-10-20, role: administrateur, permanent_representative: Denis Dufrane · Theracell Consulting
- Mandate term: end_condition: issue de l’assemblée annuelle de 2027, approuvant les comptes relatifs à l’exercice social se clôturant le 31 décembre 2026 · Jean Pierre Bizet
- Mandate compensation: non rémunéré · Jean Pierre Bizet
- General meeting: 2024-05-14 · NOVADIP BIOSCIENCES
- Officer resignation: date: 2024-02-12, role: administrateur · SOPARTEC
- Officer appointment: date: 2024-02-12, role: administrateur, duration: durée illimitée, permanent_representative: Philippe François Durieux · Vives Partners SRL
- Mandate compensation: non rémunéré · Vives Partners SRL
- Officer resignation: role: administrateur · Philippe Monteyne
- Officer appointment: role: administrateur, presenter: Fund + · Patrick Van Beneden
- Publication: 2026-05-06
- Act object: DEMISSIONS, NOMINATIONS
Technische details
{
"facts": [
{
"type": "filing",
"quote": "D\u00E9pos\u00E9 04-05-2026",
"value": "2026-05-04",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Extrait de l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 20 octobre 2021",
"value": "2021-10-20",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "L\u2019assembl\u00E9e prend acte de la d\u00E9mission de la soci\u00E9t\u00E9 anonyme \u2018INTEGRALE\u2019, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur C\u00E9dric SACRE, en qualit\u00E9 d\u2019administrateur de la soci\u00E9t\u00E9.",
"value": {
"date": "2021-10-20",
"role": "administrateur"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer comme nouvel administrateur, conform\u00E9ment \u00E0 l\u0027article 15 des statuts, sur pr\u00E9sentation de CR-CP (Novel Ventures Limited) : Monsieur Yi Zhou, n\u00E9 en Chine, le 25 mars 1969.",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"presenter": "CR-CP (Novel Ventures Limited)"
},
"object": "e1",
"subject": "e4"
},
{
"type": "officer_reappointment",
"quote": "Et de renouveler le mandat des autres administrateurs existants, soit : 1. sur pr\u00E9sentation de NSV : Monsieur Jean Pierre Bizet;",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"presenter": "NSV"
},
"object": "e1",
"subject": "e6"
},
{
"type": "officer_reappointment",
"quote": "2. sur pr\u00E9sentation de Fund\u002B : Monsieur Philippe Monteyne;",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"presenter": "Fund\u002B"
},
"object": "e1",
"subject": "e7"
},
{
"type": "officer_reappointment",
"quote": "3. sur pr\u00E9sentation de SRIW : la soci\u00E9t\u00E9 anonyme SPARAXIS, repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Madame Christina Franssen ;",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"presenter": "SRIW",
"permanent_representative": "Christina Franssen"
},
"object": "e1",
"subject": "e8"
},
{
"type": "officer_reappointment",
"quote": "4. sur pr\u00E9sentation des Investisseurs : la soci\u00E9t\u00E9 anonyme SOPARTEC, laquelle sera repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Philippe Fran\u00E7ois Durieux;",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"presenter": "Investisseurs",
"permanent_representative": "Philippe Fran\u00E7ois Durieux"
},
"object": "e1",
"subject": "e10"
},
{
"type": "officer_reappointment",
"quote": "5. en tant qu\u2019administrateurs ind\u00E9pendants : Monsieur Eric P\u00E2ques ;",
"value": {
"date": "2021-10-20",
"role": "administrateur ind\u00E9pendant"
},
"object": "e1",
"subject": "e12"
},
{
"type": "officer_reappointment",
"quote": "6. la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Axxis V\u0026C, laquelle sera repr\u00E9sent\u00E9e pour son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Gil Beyen;",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"permanent_representative": "Gil Beyen"
},
"object": "e1",
"subject": "e13"
},
{
"type": "officer_reappointment",
"quote": "7. la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Theracell Consulting, laquelle sera repr\u00E9sent\u00E9e pour l\u2019 exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Denis Dufrane, en sa qualit\u00E9 de CEO.",
"value": {
"date": "2021-10-20",
"role": "administrateur",
"permanent_representative": "Denis Dufrane"
},
"object": "e1",
"subject": "e15"
},
{
"type": "mandate_term",
"quote": "Sauf r\u00E9\u00E9lection, leurs mandats prendront fin \u00E0 l\u2019issue de l\u2019assembl\u00E9e annuelle de 2027, approuvant les comptes relatifs \u00E0 l\u2019exercice social se cl\u00F4turant le 31 d\u00E9cembre 2026.",
"value": {
"end_condition": "issue de l\u2019assembl\u00E9e annuelle de 2027, approuvant les comptes relatifs \u00E0 l\u2019exercice social se cl\u00F4turant le 31 d\u00E9cembre 2026"
},
"object": "e1",
"subject": "e6"
},
{
"type": "mandate_compensation",
"quote": "Leur mandat n\u0027est pas r\u00E9mun\u00E9r\u00E9, \u00E0 l\u2019exception des mandats des administrateurs ind\u00E9pendants.",
"value": "non r\u00E9mun\u00E9r\u00E9",
"object": "e1",
"subject": "e6"
},
{
"type": "general_meeting",
"quote": "Extrait de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordianire des actionnaires tenue le 14 mai 2024 :",
"value": "2024-05-14",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "En effet, le 12 f\u00E9vrier 2024, la soci\u00E9t\u00E9 a \u00E9t\u00E9 inform\u00E9e du remplacement de Sopartec SA par Vives Partners SRL (num\u00E9ro d\u0027entreprise 1004.227.835) en tant qu\u0027administrateur d\u00E9l\u00E9gu\u00E9 de Vives II et, par cons\u00E9quent, du remplacement de Sopartec SA, repr\u00E9sent\u00E9e par M. Philippe Durieux, par VIVES Partners SRL, repr\u00E9sent\u00E9e par M. Philippe Durieux, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9.",
"value": {
"date": "2024-02-12",
"role": "administrateur"
},
"object": "e1",
"subject": "e10"
},
{
"type": "officer_appointment",
"quote": "Le conseil d\u0027administration a d\u00E9cid\u00E9 de nommer par cooptation, avec effet imm\u00E9diat, VIVES Partners SRL, repr\u00E9sent\u00E9e par M. Philippe Durieux, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, pour une dur\u00E9e illimit\u00E9e.",
"value": {
"date": "2024-02-12",
"role": "administrateur",
"duration": "dur\u00E9e illimit\u00E9e",
"permanent_representative": "Philippe Fran\u00E7ois Durieux"
},
"object": "e1",
"subject": "e17"
},
{
"type": "mandate_compensation",
"quote": "Le mandat de VIVES Partners SRL, repr\u00E9sent\u00E9e par M. Philippe Durieux, n\u0027est pas r\u00E9mun\u00E9r\u00E9.",
"value": "non r\u00E9mun\u00E9r\u00E9",
"object": "e1",
"subject": "e17"
},
{
"type": "officer_resignation",
"quote": "Conform\u00E9ment \u00E0 la d\u00E9cision pr\u00E9c\u00E9dente du Conseil d\u0027administration, M. Patrick Van Beneden a \u00E9t\u00E9 coopt\u00E9 en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 (sur proposition de Fund \u002B ), en remplacement de M. Philippe Monteyne.",
"value": {
"role": "administrateur"
},
"object": "e1",
"subject": "e7"
},
{
"type": "officer_appointment",
"quote": "Conform\u00E9ment \u00E0 la d\u00E9cision pr\u00E9c\u00E9dente du Conseil d\u0027administration, M. Patrick Van Beneden a \u00E9t\u00E9 coopt\u00E9 en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 (sur proposition de Fund \u002B ), en remplacement de M. Philippe Monteyne.",
"value": {
"role": "administrateur",
"presenter": "Fund \u002B"
},
"object": "e1",
"subject": "e18"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 06/05/2026",
"value": "2026-05-06",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte : DEMISSIONS, NOMINATIONS",
"value": "DEMISSIONS, NOMINATIONS",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 7588,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0535.575.602",
"kind": "company",
"name": "NOVADIP BIOSCIENCES",
"attrs": {
"seat": "Rue Granbonpr\u00E9 11, 1435 Mont-Saint-Guibert",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "INTEGRALE",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "C\u00E9dric SACRE",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Yi Zhou",
"attrs": {
"birth_date": "1969-03-25",
"birth_country": "Chine"
}
},
{
"id": "e5",
"kbo": null,
"kind": "company",
"name": "CR-CP",
"attrs": {
"also_known_as": "Novel Ventures Limited"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Jean Pierre Bizet",
"attrs": {
"presenter": "NSV"
}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Philippe Monteyne",
"attrs": {
"presenter": "Fund\u002B"
}
},
{
"id": "e8",
"kbo": null,
"kind": "company",
"name": "SPARAXIS",
"attrs": {
"presenter": "SRIW",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Christina Franssen",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e10",
"kbo": null,
"kind": "company",
"name": "SOPARTEC",
"attrs": {
"presenter": "Investisseurs",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Philippe Fran\u00E7ois Durieux",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Eric P\u00E2ques",
"attrs": {
"role": "administrateur ind\u00E9pendant"
}
},
{
"id": "e13",
"kbo": null,
"kind": "company",
"name": "Axxis V\u0026C",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Gil Beyen",
"attrs": {
"role": "repr\u00E9sentant permanent"
}
},
{
"id": "e15",
"kbo": null,
"kind": "company",
"name": "Theracell Consulting",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Denis Dufrane",
"attrs": {
"role": "repr\u00E9sentant permanent",
"title": "CEO"
}
},
{
"id": "e17",
"kbo": "1004.227.835",
"kind": "company",
"name": "Vives Partners SRL",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Patrick Van Beneden",
"attrs": {
"presenter": "Fund \u002B"
}
},
{
"id": "e19",
"kbo": null,
"kind": "person",
"name": "Drew Trivisonno",
"attrs": {}
},
{
"id": "e20",
"kbo": null,
"kind": "company",
"name": "Deloitte R\u00E9viseurs d\u2019Entreprises SRL",
"attrs": {
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
}
},
{
"id": "e21",
"kbo": null,
"kind": "person",
"name": "Julie Delforge",
"attrs": {
"role": "repr\u00E9sentant"
}
},
{
"id": "e22",
"kbo": null,
"kind": "person",
"name": "Jason Zhou",
"attrs": {}
},
{
"id": "e23",
"kbo": null,
"kind": "company",
"name": "Novel Ventures Limited",
"attrs": {
"also_known_as": "CR-CP"
}
},
{
"id": "e24",
"kbo": null,
"kind": "person",
"name": "Da Liu",
"attrs": {
"role": "repr\u00E9sentant permanent",
"birth_date": "1970-09-08"
}
},
{
"id": "e25",
"kbo": null,
"kind": "person",
"name": "Peter Van Melkebeke",
"attrs": {
"role": "Notaire"
}
}
]
}09-01-2024 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-01-09",
"filing_date": "2024-01-05",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-13",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": {
"summary": "Les actionnaires ont renonc\u00E9 \u00E0 l\u0027\u00E9tablissement du rapport du conseil d\u0027administration sur la justification du prix d\u0027\u00E9mission et du rapport du commissaire, conform\u00E9ment \u00E0 l\u0027article 7:179 du Code des soci\u00E9t\u00E9s et des associations.",
"articles": [
"7:179"
]
},
"restructuring": {
"parties": [
{
"kbo": "0535.575.602",
"name": "NOVADIP BIOSCIENCES",
"role": "other",
"address": "Rue Granbonpr\u00E9 11, 1435 Mont-Saint-Guibert",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "Banque Europ\u00E9enne d\u0027Investissement",
"role": "recipient",
"address": null,
"is_foreign": true,
"legal_form": "institution",
"is_new_company": false,
"jurisdiction_country": "EU"
}
],
"exchange_ratio": null,
"legal_articles": [
"7:155",
"7:180",
"7:179"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 43315,
"real_estate_included": false,
"patrimony_description": "L\u0027op\u00E9ration consiste en l\u0027\u00E9mission de 43.315 \u00AB Warrants EIB \u00BB donnant droit \u00E0 souscrire \u00E0 une nouvelle action de classe B, ainsi qu\u0027en une augmentation du capital de la soci\u00E9t\u00E9 par \u00E9mission d\u0027actions de classe B nouvelles, sous condition suspensive de l\u0027exercice des warrants. Le patrimoine transf\u00E9r\u00E9 concerne les droits de souscription et les actions \u00E9mises.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de NOVADIP BIOSCIENCES, r\u00E9unie le 13 d\u00E9cembre 2023, a d\u00E9cid\u00E9 d\u0027\u00E9mettre 43.315 warrants gratuits \u00E0 la Banque Europ\u00E9enne d\u0027Investissement, donnant droit \u00E0 souscrire \u00E0 des actions de classe B. Elle a approuv\u00E9 les conditions de ces warrants, approuv\u00E9 une augmentation de capital sous condition suspensive de leur exercice, et modifi\u00E9 les statuts pour garantir des droits financiers \u00E9quivalents aux actionnaires de classe B. Des pouvoirs ont \u00E9t\u00E9 conf\u00E9r\u00E9s aux administrateurs pour ex\u00E9cuter les d\u00E9cisions prises.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"liste de pr\u00E9sence",
"une procuration",
"le rapport sp\u00E9cial du conseil d\u0027administration \u00E9tabli en application des articles 7:155 et 7:180 du Code des soci\u00E9t\u00E9s et des associations",
"le rapport du commissaire \u00E9tabli en application des articles 7:155 et 7:180 du Code des soci\u00E9t\u00E9s et des associations",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "capital_shares"
}04-08-2023 Kapitaalverhoging van €209.000 tot €8.199.166,39
- €7.990.166,39 → €8.199.166,39
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 209000,
"currency": "EUR",
"after_eur": 8199166.39,
"delta_eur": 209000.0,
"before_eur": 7990166.39,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-07-28",
"evidence_quote": "Le capital a \u00E9t\u00E9 augment\u00E9 \u00E0 concurrence de 209.000 EUR et port\u00E9 de 7.990.166,39 EUR \u00E0 8.199.166,39 EUR. La diff\u00E9rence entre la valeur totale de souscription (1.567.500 EUR) et le montant de l\u2019augmentation de capital (209.000 EUR), soit 1.358.500 EUR est affect\u00E9 en tant que prime d\u2019\u00E9mission. Ladite augmentation du capital est r\u00E9alis\u00E9e par l\u2019\u00E9mission de 20.900 nouvelles actions de classe A2... Les 20.900 nouvelles actions de classe A2 ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}28-11-2022 Julie Delforge benoemd tot commissaris
- Julie Delforge, Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Julie Delforge",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de nommer Deloitte R\u00E9viseurs d\u0027Entreprises SRL, r\u00E9pr\u00E9sent\u00E9e par Julie Delforge comme commissaire."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}10-10-2022 Kapitaalverhoging van €898.390 tot €7.890.230
- €6.991.840 → €7.890.230
- 3 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 898390.0,
"currency": "EUR",
"after_eur": 7890230.0,
"delta_eur": 898390.0,
"before_eur": 6991840.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-09-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u2019augmenter le capital, \u00E0 concurrence de huit cent nonante-huit mille trois cent nonante euros (898.390,00 EUR), pour le porter de six millions neuf cent nonante-et-un mille huit cent quarante euros (6.991.840,00 EUR) \u00E0 sept millions huit cent nonante mille deux cent trente euros (7.890.230,00 EUR) ... Ces actions nouvelles seront souscrites et int\u00E9gralement lib\u00E9r\u00E9es en esp\u00E8ces",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 496.39,
"currency": "EUR",
"after_eur": 7890726.39,
"delta_eur": 496.39,
"before_eur": 7890230.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-10-06",
"evidence_quote": "que l\u0027augmentation de capital qui en r\u00E9sulte d\u0027un montant de quatre cent nonante-six euros trente-neuf cents (496,39 EUR) est effectivement r\u00E9alis\u00E9e et que le capital est ainsi port\u00E9 de sept millions huit cent nonante mille deux cent trente euros (7.890.230,00 EUR) \u00E0 sept millions huit cent nonante mille sept cent vingt-six euros trente-neuf cent (7.890.726,39 EUR)",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 99440.0,
"currency": "EUR",
"after_eur": 7990166.39,
"delta_eur": 99440.0,
"before_eur": 7890726.39,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-10-06",
"evidence_quote": "que l\u0027augmentation de capital qui en r\u00E9sulte d\u0027un montant de nonante-neuf mille quatre cent quarante euros (99.440,00 EUR) est effectivement r\u00E9alis\u00E9e et que le capital est ainsi port\u00E9 de sept millions huit cent nonante mille sept cent vingt-six euros trente-neuf cent (7.890.726,39 EUR) \u00E0 sept millions huit cent nonante mille sept cent nonante mille cent soixante-six euros et trente-neuf cents (7.990.166,39 EUR)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}24-05-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-05-10",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}23-02-2022 Kapitaalverhoging van €93.200 tot €6.870.510
- €6.777.310 → €6.870.510
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 93200.0,
"currency": "EUR",
"after_eur": 6870510.0,
"delta_eur": 93200.0,
"before_eur": 6777310.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-12-10",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u2019augmenter le capital, \u00E0 concurrence nonante-trois mille deux cents euros (93.200,00 EUR), pour le porter de six millions sept cent septante-sept mille huit trois cent dix euros (6.777.310,00 EUR) \u00E0 six millions huit cent septante mille cinq cent dix euros (6.870.510,00 EUR), par la cr\u00E9ation de neuf mille trois cent vingt (9.320) actions nouvelles de cat\u00E9gorie B, sans d\u00E9signation de valeur nominale, du m\u00EAme type et jouissant des m\u00EAmes droits et avantages que les actions de cat\u00E9gorie B existantes.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}03-11-2021 1 bestuurder benoemd, 7 herbenoemd
- Yi Zhou, Bestuurder
- Jean Pierre Bizet, Bestuurder
- Philippe Monteyne, Bestuurder
- Christina Franssen, Bestuurder
- Philippe François Durieux, Bestuurder
- Eric Pâques, Bestuurder
- Gil Beyen, Bestuurder
- Denis Dufrane, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yi Zhou",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de nommer comme nouvel administrateur, conform\u00E9ment \u00E0 l\u0027article 15 des statuts, sur pr\u00E9sentation de CR-CP (Novel Ventures Limited) : Monsieur Yi Zhou, n\u00E9 en Chine, le 25 mars 1969, domicili\u00E9 \u00E0 Flat D, 1/F, Tower 8, Ocean Wings 28 Tong Chu Street, Tseung Kwan O New Territories, Hon"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean Pierre Bizet",
"address": null,
"birth_date": null
},
"evidence_quote": "Et de renouveler le mandat des autres administrateurs existants, soit : 1. sur pr\u00E9sentation de NSV : Monsieur Jean Pierre Bizet;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Monteyne",
"address": null,
"birth_date": null
},
"evidence_quote": "2. sur pr\u00E9sentation de Fund\u002B : Monsieur Philippe Monteyne;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christina Franssen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SPARAXIS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "3. sur pr\u00E9sentation de SRIW : la soci\u00E9t\u00E9 anonyme SPARAXIS, repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Madame Christina Franssen ;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Fran\u00E7ois Durieux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SOPARTEC",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "4. sur pr\u00E9sentation des Investisseurs : la soci\u00E9t\u00E9 anonyme SOPARTEC, laquelle sera repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Philippe Fran\u00E7ois Durieux;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric P\u00E2ques",
"address": null,
"birth_date": null
},
"evidence_quote": "5. en tant qu\u2019administrateurs ind\u00E9pendants : Monsieur Eric P\u00E2ques ;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gil Beyen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Axxis V\u0026C",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "6. la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Axxis V\u0026C, laquelle sera repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Gil Beyen;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Denis Dufrane",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Theracell Consulting",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "7. la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e Theracell Consulting, laquelle sera repr\u00E9sent\u00E9e pour l\u2019exercice de son mandat d\u0027administrateur par son repr\u00E9sentant permanent, d\u00E9sign\u00E9 conform\u00E9ment \u00E0 l\u0027article 2 :55 du Code des soci\u00E9t\u00E9s et associations, \u00E9tant Monsieur Denis Dufrane, en sa qualit\u00E9 de CEO."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}23-09-2020 Kapitaalverhoging van €75.000 tot €5.286.860
- €5.211.860 → €5.286.860
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 75000,
"currency": "EUR",
"after_eur": 5286860,
"delta_eur": 75000,
"before_eur": 5211860,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-09-03",
"evidence_quote": "l\u0027augmentation de capital qui en r\u00E9sulte d\u0027un montant de septante-cinq mille euros (75.000,00 EUR) est effectivement r\u00E9alis\u00E9e et que le capital social est ainsi port\u00E9 de cinq millions deux cent onze mille huit cent soixante euros (5.211.860,00 EUR) \u00E0 cinq millions deux cent quatre-vingt-six mille huit cent soixante euros (5.286.860,00 EUR)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}16-03-2020 1 bestuurder benoemd, 1 ontslagnemend
- Dr Denis Dufrane, Gedelegeerd bestuurder
- Jeff Abbey, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeff Abbey",
"address": null,
"birth_date": null
},
"effective_date": "2019-12-23",
"evidence_quote": "Prendre acte de la d\u00E9mission de M. Jeff Abbey de ses fonctions d\u0027administrateur de la soci\u00E9t\u00E9, et de la fin de son mandat de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re (CEO), avec effet \u00E0 compter du 23 d\u00E9cembre 2019;"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Dr Denis Dufrane",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0535788408",
"name": "Theracell Consulting",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Nommer Theracell Consulting, soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e de droit belge, dont le si\u00E8ge social est situ\u00E9 \u00E0 1380 Lasne, rue \u00E0 Fossant 18, inscrite aupr\u00E8s de la Banque Carrefour des Entreprises sous le num\u00E9ro 0535.788.408, repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Dr Denis Dufrane, en tant qu\u0027adm"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}01-10-2019 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2019-10-01",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}01-07-2019 1 bestuurder benoemd, 1 ontslagnemend, 6 herbenoemd
- Eric Pâques, Bestuurder
- Eric Pâques, Bestuurder
- Cédric Sacré, Bestuurder
- Christine Franssen, Bestuurder
- Philippe Monteyne, Bestuurder
- Jean-Pierre Bizet, Bestuurder
- Philippe Durieux, Bestuurder
- Patrick Mortroux, Commissaris
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric P\u00E2ques",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Aetes GmbH",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale accepte \u00E0 l\u0027unanimit\u00E9 la d\u00E9mission de la soci\u00E9t\u00E9 de droit allemand Aetes GmbH, Ronheider Berg 255, 52076 Aachen (Allemagne), repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Eric P\u00E2ques, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric P\u00E2ques",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme \u00E0 l\u0027unanimit\u00E9 Monsieur Eric P\u00E2ques en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "C\u00E9dric Sacr\u00E9",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Int\u00E9grale",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler les mandats des administrateurs suivants pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023: -Int\u00E9grale, place Saint-Jacques 11 bte 101, 4000 Li\u00E8ge, repr\u00E9sent\u00E9e par Monsieur C\u00E9dric Sa"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christine Franssen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Sparaxis SA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler les mandats des administrateurs suivants pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023: ... -Sparaxis SA, avenue Maurice Destemay 13, 4000 Li\u00E8ge, repr\u00E9sent\u00E9e par Madame Christine"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Monteyne",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler les mandats des administrateurs suivants pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023: ... -Monsieur Philippe Monteyne, all\u00E9e du Bois de Bercuit 101, 1390 Grez Doiceau;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Pierre Bizet",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler les mandats des administrateurs suivants pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023: ... -Monsieur Jean-Pierre Bizet, rue des Saints P\u00E8res 14, 75007 Paris, France;"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe Durieux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Sopartec SA",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de renouveler les mandats des administrateurs suivants pour une dur\u00E9e de 4 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027ann\u00E9e 2023: ... -Sopartec SA, place de l\u0027Universit\u00E9 1, 1348 Louvain-la-Neuve, repr\u00E9sent\u00E9e par Monsieur"
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Patrick Mortroux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC R\u00E9viseurs d\u0027Entreprises SCRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Elle d\u00E9cide de renouveler le mandat de la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e PwC R\u00E9viseurs d\u0027Entreprises, Woluwedal 18, 1932 Sint-Stevens-Woluwe, repr\u00E9sent\u00E9e par Monsieur Patrick Mortroux, pour une dur\u00E9e de 3 ans, venant \u00E0 expiration imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de l\u0027"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}12-02-2019 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}30-01-2019 2 bestuurders benoemd, 2 ontslagnemend
- Jeffrey David ABBEY, Bestuurder
- Gil BEYEN, Bestuurder
- Jean-François Pollet, Bestuurder
- Gil Beyen, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Fran\u00E7ois Pollet",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0536192442",
"name": "CONTHEGAS Consulting",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2018-12-31",
"evidence_quote": "Ladite assembl\u00E9e a d\u00E9cid\u00E9 d\u2019acter la d\u00E9mission de la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e CONTHEGAS Consulting, ayant son si\u00E8ge social \u00E0 1367 Geest-G\u00E9rompont-Petit-Rosi\u00E8re, rue R. Pierre 4, identifi\u00E9e sous le num\u00E9ro d\u2019entreprise TVA BE 0536.192.442 (RPM Brabant Wallon), repr\u00E9sent\u00E9e par Monsieur J"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gil Beyen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0478778043",
"name": "GIL BEYEN",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2018-12-20",
"evidence_quote": "Ladite assembl\u00E9e a d\u00E9cid\u00E9 d\u2019acter la d\u00E9mission de la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e GIL BEYEN, ayant son si\u00E8ge social \u00E0 3053 Oud-Heverlee, Boetsenberg 20, identifi\u00E9e sous le num\u00E9ro d\u2019entreprise TVA BE 0478.778.043 (RPM Louvain - division Oud Heverlee), repr\u00E9sent\u00E9e par Monsieur Gil Beyen, en"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeffrey David ABBEY",
"address": null,
"birth_date": null
},
"effective_date": "2019-01-01",
"evidence_quote": "Ladite assembl\u00E9e a d\u00E9cid\u00E9 de nommer Monsieur Jeffrey David ABBEY, n\u00E9 \u00E0 New York (Etats-Unis d\u2019 Am\u00E9rique), le 5 mars 1962, domicili\u00E9 \u00E0 735 Gimghoul Road, Chapel Hill, NC 27514, Etats-Unis d\u2019 Am\u00E9rique, en qualit\u00E9 d\u2019administrateur, \u00E0 partir du 1er janvier 2019."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gil BEYEN",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0464259123",
"name": "AXXISS V\u0026C",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2018-12-20",
"evidence_quote": "Ladite assembl\u00E9e a d\u00E9cid\u00E9 de nommer la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e AXXISS V\u0026C, ayant son si\u00E8ge social \u00E0 3053 Oud-Heverlee, Boetsenberg 18, identifi\u00E9e sous le num\u00E9ro d\u2019entreprise TVA BE 0464.259.123 (RPM Louvain \u2013 division Oud Heverlee), laquelle sera repr\u00E9sent\u00E9e pour l\u2019exercice de son ma"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}07-05-2018 Kapitaalverhoging van €922.680 tot €4.289.180
- €3.366.500 → €4.289.180
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 922680.0,
"currency": "EUR",
"after_eur": 4289180.0,
"delta_eur": 922680.0,
"before_eur": 3366500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2018-03-28",
"evidence_quote": "d\u2019augmenter le capital social \u00E0 concurrence de neuf cent vingt-deux mille six cents quatre-vingts euros (922.680,00 EUR), pour le porter de trois millions trois cent soixante-six mille cinq cents euros (3.366.500,00 EUR) \u00E0 quatre millions deux cent quatre-vingt-neuf mille cent quatre-vingts euros (4.289.180,00 EUR), par la cr\u00E9ation de nonante-deux mille deux cent soixante-huit (92.268) actions de cat\u00E9gorie A2 nouvelles... Ces actions nouvelles de cat\u00E9gorie A2 seront souscrites et int\u00E9gralement lib\u00E9r\u00E9es en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}06-06-2017 Eric Pâques benoemd tot bestuurder
- Eric Pâques, Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Eric P\u00E2ques",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Aetes GmbH",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer Aetes GmbH (adresse Ronheider Berg 255. 52076 Aachen, Allemagne n\u00B0 d\u0027entreprise DE 306202644), repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent, Monsieur Eric P\u00E2ques, comme administrateur ind\u00E9pendant pour une dur\u00E9e de trois ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}26-07-2016 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Vincent Vroninks",
"firm_city": null,
"firm_name": null,
"office_city": "Mons",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2016-07-26",
"filing_date": "2016-05-10",
"act_kind_objet": "D\u00E9p\u00F4t:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2016-05-10",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0535.575.602",
"name": "NOVADIP BIOSCIENCES",
"role": "other",
"address": "Rue Granbonpr\u00E9 11 - 1435 Mons-Saint-Guibert",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne l\u0027\u00E9mission de warrants SOP 2016 et la rectification d\u0027une erreur mat\u00E9rielle dans les statuts.",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Vincent Vroninks",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de la soci\u00E9t\u00E9 anonyme NOVADIP BIOSCIENCES, tenue le 10 mai 2016 par Ma\u00EEtre Vincent Vroninks, a d\u00E9cid\u00E9 l\u0027\u00E9mission de warrants SOP 2016 sans modification des statuts. Par ailleurs, les statuts ont \u00E9t\u00E9 coordonn\u00E9s le 3 mars 2016 pour corriger une erreur mat\u00E9rielle survenue dans les versions ant\u00E9rieures concernant les articles 20 et 21.",
"co_filed_documents": [
"Statuts coordonn\u00E9s du 3 mars 2016",
"Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 10 mai 2016"
],
"detected_real_type": "other",
"referenced_correction": {
"prior_pub_date": "2015-09-18",
"what_corrected": "erreur mat\u00E9rielle dans les articles 20 et 21 des statuts coordonn\u00E9s d\u00E9pos\u00E9s le 18 septembre 2015 et le 13 avril 2016",
"prior_pub_number": "24392906"
},
"should_reroute_to_category": "statutes"
}03-06-2016 Patrick Mortroux herbenoemd als commissaris
- Patrick Mortroux, Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Patrick Mortroux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0429501944",
"name": "PwC Reviseurs d\u0027Entreprises SC SCRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer PwC Reviseurs d\u0027Entreprises SC SCRL, ayant son si\u00E8ge social \u00E0 Wo\u0142uwedal 18, 1932 Sint-Stevens-Woluwe (RPM Bruxelles 0429.501.944), repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Patrick Mortroux comme commissaire de la Soci\u00E9t\u00E9 pour une dur\u00E9e de trois ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}22-04-2016 Kapitaalverhoging van €1.258.250 tot €3.366.500
- €2.108.250 → €3.366.500
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 1258250.0,
"currency": "EUR",
"after_eur": 3366500.0,
"delta_eur": 1258250.0,
"before_eur": 2108250.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2016-03-03",
"evidence_quote": "d\u0027augmenter le capital social \u00E0 concurrence d\u0027un million deux cent cinquante-huit mille deux cent cinquante euros (1.258.250,00 EUR), pour le porter de deux millions cent huit mille deux cent cinquante euros (2.108.250,00 EUR) \u00E0 trois millions trois cent soixante-six mille cinq cents euros (3.366.500,00 EUR), par la cr\u00E9ation de cent vingt-cinq mille huit cent vingt-cing (125.825) actions nouvelles de cat\u00E9gorie A1, sans d\u00E9signation de valeur nominale, jouissant des m\u00EAmes droits et avantages que les actions de cat\u00E9gorie A1 existantes. [...] Les actions nouvelles seront souscrtes et int\u00E9gralement lib\u00E9r\u00E9es en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}20-01-2016 Zetelverplaatsing van Ottignies-Louvain-La-Neuve naar Mont-Saint-Guibert
- Chemin Du Cyclotron 6, 1348 Ottignies-Louvain-La-Neuve → Rue Granbonpré 11, 1435 Mont-Saint-Guibert
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mont-Saint-Guibert",
"region": "Waals",
"street": "Rue Granbonpr\u00E9",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "11"
},
"old_address": {
"city": "Ottignies-Louvain-La-Neuve",
"region": "Waals",
"street": "Chemin Du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": "13",
"street_number": "6"
},
"effective_date": "2016-01-08",
"evidence_quote": "Le conseil d\u00E9cide le transfert de si\u00E8ge social \u00E0 partir de ce jour vers 11 Rue Granbonpr\u00E9 - 1435 Mont-Saint-Guibert."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}30-09-2015 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}29-07-2015 Kapitaalverhoging van €300.000 tot €850.000
- €550.000 → €850.000
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 300000,
"currency": "EUR",
"after_eur": 850000,
"delta_eur": 300000,
"before_eur": 550000,
"amount_type": "kapitaal_effectief",
"effective_date": "2015-06-26",
"evidence_quote": "d\u0027augmenter le capital social \u00E0 concurrence de trois cent mille euros (300.000,00 EUR) pour le porter de cir\u0131q cent cinquarite mille euros (550.000,00 EUR) \u00E0 huit cent cinquante mille euros (850.000,00 EUR), par la cr\u00E9ation de trente mille (30.000) actions nouvelles... En contrepartie de l\u0027apport... 30.000 actions... seront \u00E9mises et attribu\u00E9es... Je rappelle enfin que ma miss\u00EDon ne pr\u00E9voit pas de me prononcer sur le caract\u00E8re l\u00E9gitime et \u00E9quitable de l\u0027op\u00E9ration. \u003E",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}26-06-2015 2 bestuurders benoemd
- Gil Beyen, Bestuurder
- Jean-François POLLET, Gedelegeerd bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gil Beyen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0478778043",
"name": "Gil Beyen",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide d\u0027appeler \u00E0 la fonction d\u0027administrateur, pour un terme qui expirera imm\u00E9diatement apr\u00E8s l\u0027assembl\u00E9e annuelle de 2019, approuvant les comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2018, la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB Gil Beyen \u00BB, ayant son si\u00E8ge social \u00E0 3035 Haasr"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jean-Fran\u00E7ois POLLET",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "CONTHEGAS SPRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "CONTHEGAS SPRL, repr\u00E9sent\u00E9 par Jean-Fran\u00E7ois POLLET Administrateur D\u00E9l\u00E9gu\u00E9"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0535.575.602",
"name_full": "NOVADIP BIOSCIENCES",
"legal_form": "SA"
}
}| Officiële naamFR | NOVADIP BIOSCIENCES |